The winners, Nathan Gates, Faith Apostolodes, and Kevin Helm have shared some insights as to what inspired their winning ...

DIA, a global multidisciplinary life sciences membership association, will bring together thousands of stakeholders from all ...

Vertex' outgoing R&D chief Peter Mueller - who has just announced his retirement - must feel he is leaving the company in fine shape.

Cupid is the symbol of love: here is how he was represented in the art of Correggio, Caravaggio, Manfredi, and Parmigianino, between light and shadow, passion and fragility.

This file provides functions and modules that construct shapes from a list of cross sections ... with many edges meeting at each polygon vertex. The result is an alternation of flat triangular faces ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...

Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business.

BOSTON—Ourania Tatsis, Executive Vice President and Chief Regulatory and Quality Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a $116 billion market cap biotech company currently trading near ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has many promising treatments in its pipeline, as it looks to build out its business beyond just the cystic fibrosis (CF) drugs that have enabled it to post ...

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...